1. Home
  2. TNK vs BEAM Comparison

TNK vs BEAM Comparison

Compare TNK & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNK
  • BEAM
  • Stock Information
  • Founded
  • TNK 2007
  • BEAM 2017
  • Country
  • TNK Bermuda
  • BEAM United States
  • Employees
  • TNK N/A
  • BEAM N/A
  • Industry
  • TNK Marine Transportation
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TNK Consumer Discretionary
  • BEAM Health Care
  • Exchange
  • TNK Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • TNK 1.6B
  • BEAM 1.6B
  • IPO Year
  • TNK 2007
  • BEAM 2020
  • Fundamental
  • Price
  • TNK $45.38
  • BEAM $16.76
  • Analyst Decision
  • TNK Buy
  • BEAM Strong Buy
  • Analyst Count
  • TNK 3
  • BEAM 11
  • Target Price
  • TNK $50.67
  • BEAM $48.90
  • AVG Volume (30 Days)
  • TNK 458.3K
  • BEAM 1.8M
  • Earning Date
  • TNK 07-31-2025
  • BEAM 08-05-2025
  • Dividend Yield
  • TNK 4.39%
  • BEAM N/A
  • EPS Growth
  • TNK N/A
  • BEAM N/A
  • EPS
  • TNK 9.52
  • BEAM N/A
  • Revenue
  • TNK $1,092,689,000.00
  • BEAM $63,578,000.00
  • Revenue This Year
  • TNK N/A
  • BEAM N/A
  • Revenue Next Year
  • TNK N/A
  • BEAM $8.82
  • P/E Ratio
  • TNK $4.90
  • BEAM N/A
  • Revenue Growth
  • TNK N/A
  • BEAM N/A
  • 52 Week Low
  • TNK $33.35
  • BEAM $13.53
  • 52 Week High
  • TNK $72.30
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • TNK 51.95
  • BEAM 44.29
  • Support Level
  • TNK $45.09
  • BEAM $16.18
  • Resistance Level
  • TNK $47.99
  • BEAM $18.33
  • Average True Range (ATR)
  • TNK 1.61
  • BEAM 1.10
  • MACD
  • TNK 0.04
  • BEAM 0.00
  • Stochastic Oscillator
  • TNK 55.79
  • BEAM 28.65

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the global oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: